Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-02 Sale | 2026-02-04 8:23 pm | OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Operating Officer | 11,490 | $8.8249 | $101,398 | 377,802 (Direct) | View |
| 2025-11-24 Sale | 2025-11-26 4:02 pm | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 1,878 | $12.04 | $22,611 | 277,860 (Direct) | View |
| 2025-11-24 Sale | 2025-11-26 4:02 pm | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 19,530 | $12.04 | $235,141 | 3,458,075 (Indirect Direct) | View |
| 2025-11-24 Sale | 2025-11-26 4:01 pm | OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer | 3,007 | $12.02 | $36,144 | 191,433 (Direct) | View |
| 2025-11-24 Sale | 2025-11-26 4:01 pm | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer | 3,469 | $12.04 | $41,767 | 245,940 (Direct) | View |
| 2025-11-05 Sale | 2025-11-07 4:01 pm | OCULAR THERAPEUTIX INC | OCUL | Saroj Namrata Chief Business Officer | 25,865 | $10.74 | $277,790 | 174,135 (Direct) | View |
| 2025-10-08 Sale | 2025-10-10 4:01 pm | OCULAR THERAPEUTIX INC | OCUL | Anderman Todd Chief Legal Officer | 11,132 | $12.34 | $137,369 | 87,568 (Direct) | View |
| 2025-10-02 Sale | 2025-10-06 5:13 pm | OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer | 9,653 | $11.03 | $106,473 | 194,440 (Direct) | View |
| 2025-10-02 Sale | 2025-10-06 5:10 pm | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer | 10,502 | $11.04 | $115,942 | 249,409 (Direct) | View |
| 2025-09-02 Sale | 2025-09-04 4:50 pm | OCULAR THERAPEUTIX INC | OCUL | Notman Donald See Remarks | 1,066 | $12.43 | $13,250 | 308,807 (Direct) | View |
| 2025-08-25 Sale | 2025-08-27 6:44 pm | OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer | 3,011 | $12.04 | $36,252 | 204,093 (Direct) | View |
| 2025-08-25 Sale | 2025-08-27 6:43 pm | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 1,885 | $12.04 | $22,695 | 279,738 (Direct) | View |
| 2025-08-25 Sale | 2025-08-27 6:42 pm | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer | 3,063 | $12.04 | $36,879 | 259,911 (Direct) | View |
| 2025-08-25 Sale | 2025-08-27 6:41 pm | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 21,494 | $12.04 | $258,788 | 3,477,605 (Indirect Direct) | View |
| 2025-06-02 Sale | 2025-06-03 4:20 pm | OCULAR THERAPEUTIX INC | OCUL | Waheed Nadia Chief Medical Officer | 13,861 | $8.05 | $111,581 | 206,805 (Direct) | View |
| 2025-05-23 Sale | 2025-05-27 5:42 pm | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 1,862 | $7.17 | $13,351 | 281,623 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-21 Option Award | 2026-01-26 7:15 pm | N/A 2036-01-20 | OCULAR THERAPEUTIX INC | OCUL | Robinson David Wayne Global CCO | 552,000 | $0 | 552,000 (Direct) | View |
| 2026-01-20 Option Award | 2026-01-22 6:41 pm | N/A 2036-01-19 | OCULAR THERAPEUTIX INC | OCUL | Robins Jason Shand Interim CFO | 33,000 | $0 | 33,000 (Direct) | View |
Ownership | 2026-01-22 6:39 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Robins Jason Shand Interim CFO | 0 | $0 | 231,451 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:07 pm | N/A 2036-01-01 | OCULAR THERAPEUTIX INC | OCUL | Anderman Todd Chief Legal Officer | 262,550 | $0 | 350,118 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:06 pm | N/A 2036-01-01 | OCULAR THERAPEUTIX INC | OCUL | Meyers Steve Lawrence Chief Commercial Officer | 262,550 | $0 | 415,278 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:06 pm | N/A 2036-01-01 | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 262,550 | $0 | 540,410 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:05 pm | N/A 2036-01-01 | OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer | 320,044 | $0 | 512,850 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:04 pm | N/A 2036-01-01 | OCULAR THERAPEUTIX INC | OCUL | Saroj Namrata Chief Business Officer | 320,044 | $0 | 495,552 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:04 pm | N/A 2036-01-01 | OCULAR THERAPEUTIX INC | OCUL | Waheed Nadia Chief Medical Officer | 320,044 | $0 | 567,212 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:03 pm | N/A 2036-01-01 | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer | 320,044 | $0 | 567,357 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:01 pm | N/A 2036-01-01 | OCULAR THERAPEUTIX INC | OCUL | Notman Donald See Remarks | 320,044 | $0 | 630,224 (Direct) | View |
| 2025-11-26 Gift | 2025-11-26 4:02 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 49,754 | $0 | 3,458,075 (Indirect) | View |
| 2025-09-09 Gift | 2025-09-11 4:06 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 49,754 | $0 | 3,477,605 (Direct) | View |
| 2025-08-12 Option Award | 2025-08-14 5:51 pm | N/A 2035-08-11 | OCULAR THERAPEUTIX INC | OCUL | Waheed Nadia Chief Medical Officer | 163,286 | $0 | 370,091 (Direct) | View |
| 2025-04-28 Gift | 2025-08-13 7:02 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 500,722 | $0 | 3,499,099 (Direct) | View |
Ownership | 2025-06-23 9:12 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Meyers Steve Lawrence Chief Commercial Officer | 0 | $0 | 664,728 (Direct) | View |
Ownership | 2025-06-23 9:09 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Saroj Namrata Chief Business Officer | 0 | $0 | 666,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:26 pm | N/A 2035-02-11 | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 2,750,000 | $0 | 2,750,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:26 pm | N/A 2035-06-10 | OCULAR THERAPEUTIX INC | OCUL | Hong Seung Suh Director | 58,000 | $0 | 90,933 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:25 pm | N/A 2035-06-10 | OCULAR THERAPEUTIX INC | OCUL | RAINES MERILEE Director | 58,000 | $0 | 90,933 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:24 pm | N/A 2035-06-10 | OCULAR THERAPEUTIX INC | OCUL | LINDSTROM RICHARD L MD Director | 58,000 | $0 | 230,704 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:24 pm | N/A 2035-06-10 | OCULAR THERAPEUTIX INC | OCUL | Williams Leslie J. Director | 58,000 | $0 | 95,433 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:23 pm | N/A 2035-06-10 | OCULAR THERAPEUTIX INC | OCUL | Warden Charles M Director | 58,000 | $0 | 130,464 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:21 pm | N/A 2035-06-10 | OCULAR THERAPEUTIX INC | OCUL | Graves Adrienne L Director | 58,000 | $0 | 94,000 (Direct) | View |